Dynamic contrast-enhanced MRI: Use in predicting pathological complete response to neoadjuvant chemoradiation in locally advanced rectal cancer

Journal of Magnetic Resonance Imaging

Volumn 42, Issue 3, 2015, Pages 673-680

  Tong, Tong ^a   Sun, Yiqun ^a   Gollub, Marc J ^b   Peng, Weijun ^a   Cai, Sanjun ^a   Zhang, Zhen ^a   Gu, Yajia ^a  

^a FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

chemoradiotherapy; complete pathological response; DCE MRI; rectal cancer

Indexed keywords

CAPECITABINE; OXALIPLATIN; CONTRAST MEDIUM;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CLASSIFICATION; CANCER STAGING; CHEMORADIOTHERAPY; CLINICAL ARTICLE; COHORT ANALYSIS; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PILOT STUDY; PREDICTION; PREOPERATIVE CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION DOSE; RADIOLOGICAL PARAMETERS; RECTUM CANCER; RECTUM SURGERY; SENSITIVITY ANALYSIS; TREATMENT OUTCOME; TREATMENT RESPONSE; TUMOR VOLUME; CHEMISTRY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; NEOADJUVANT THERAPY; PREOPERATIVE PERIOD; RECTAL NEOPLASMS; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

ADULT; AGED; CHEMORADIOTHERAPY; COMBINED MODALITY THERAPY; CONTRAST MEDIA; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; PILOT PROJECTS; PREOPERATIVE PERIOD; PROSPECTIVE STUDIES; RECTAL NEOPLASMS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84939253657     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.24835     Document Type: Article

References (34)

1. Maas M, Nelemans PJ, Valentini V, et al., Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data. Lancet Oncol 2010; 11: 835-844.
2. Das P, Skibber JM, Rodriguez-Bigas MA, et al., Clinical and pathologic predictors of locoregional recurrence, distant metastasis, and overall survival in patients treated with chemoradiation and mesorectal excision for rectal cancer. Am J Clin Oncol 2006; 29: 219-224.
3. Garcia-Aguilar J, Hernandez de Anda E, Sirivongs P, et al., A pathologic complete response to preoperative chemoradiation is associated with lower local recurrence and improved survival in rectal cancer patients treated by mesorectal excision. Dis Colon Rectum 2003; 46: 298-304.
4. Martin ST, Heneghan HM, Winter DC,. Systematic review and meta-analysis of outcomes following pathological complete response to neoadjuvant chemoradiotherapy for rectal cancer. Br J Surg 2012; 99: 918-928.
5. Habr-Gama A,. Assessment and management of the complete clinical response of rectal cancer to chemoradiotherapy. Colorectal Dis 2006; 8 (Suppl 3): 21-24.
6. Beets-Tan RG, Beets GL, Vliegen RF, et al., Accuracy of magnetic resonance imaging in prediction of tumor-free resection margin in rectal cancer surgery. Lancet 2001; 357: 497-504.
7. Gollub MJ, Schwartz LH, Akhurst T,. Update on colorectal cancer imaging. Radiol Clin North Am 2007; 45: 85-118.
8. van der Paardt MP, Zagers MB, Beets-Tan RG, et al., Patients who undergo preoperative chemoradiotherapy for locally advanced rectal cancer restaged by using diagnostic MR imaging: a systematic review and meta-analysis. Radiology 2013; 269: 101-112.
9. Gray LH, Conger AD, Ebert M, Hornsey S, Scott OC,. The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy. Br J Radiol 1953; 26: 638-648.
10. Overgaard J, Horsman MR,. Modification of hypoxia-induced radioresistance in tumors by the use of oxygen and sensitizers. Semin Radiat Oncol 1996; 6: 10-21.
11. Wolmark N, Piedbois P, Rougier P, et al., Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer. J Clin Oncol 1998; 16: 301-308.
12. Vaupel P, Kallinowski F, Okunieff P,. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res 1989; 49: 6449-6465.
13. Jain RK,. Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science 2005; 307: 58-62.
14. Kremser C, Trieb T, Rudisch A, et al., Dynamic T1 mapping predicts outcome of chemoradiation therapy in primary rectal carcinoma: sequence implementation and data analysis. J Magn Reson Imaging 2007; 26: 662-671.
15. Sahani DV, Kalva SP, Hamberg LM, et al., Assessing tumor perfusion and treatment response in rectal cancer with multisection CT: initial observations. Radiology 2005; 234: 785-792.
16. Dinter DJ, Horisberger K, Zechmann C, et al., Can dynamic MR imaging predict response in patients with rectal cancer undergoing cetuximab-based neoadjuvant chemoradiation? Onkologie 2009; 32: 86-93.
17. De Vries A, Griebel J, Kremser C, et al., Monitoring of tumor microcirculation during fractionated radiation therapy in patients with rectal carcinoma: preliminary results and implications for therapy. Radiology 2000; 217: 385-391.
18. DeVries AF, Griebel J, Kremser C, et al., Tumor microcirculation evaluated by dynamic magnetic resonance imaging predicts therapy outcome for primary rectal carcinoma. Cancer Res 2001; 61: 2513-2516.
19. Gollub MJ, Gultekin DH, Akin O, et al., Dynamic contrast enhanced-MRI for the detection of pathological complete response to neoadjuvant chemotherapy for locally advanced rectal cancer. Eur Radiol 2012; 22: 821-831.
20. Oberholzer K1, Menig M, Pohlmann A, et al., Rectal cancer: assessment of response to neoadjuvant chemoradiation by dynamic contrast-enhanced MRI. J Magn Reson Imaging 2013; 38: 119-126.
21. Lim JS, Kim D, Baek SE, et al., Perfusion MRI for the prediction of treatment response after preoperative chemoradiotherapy in locally advanced rectal cancer. Eur Radiol 2012; 22: 1693-1700.
22. George ML, Dzik-Jurasz ASK, Padhani AR, et al., Noninvasive methods of assessing angiogenesis and their value in predicting response to treatment in colorectal cancer. Br J Surg 2001; 88: 1628-1636.
23. Kim SH, Lee JM, Gupta SN, et al., Dynamic contrast-enhanced MRI to evaluate the therapeutic response to neoadjuvant chemoradiation therapy in locally advanced rectal cancer. J Magn Reson Imaging 2014; 40: 730-737.
24. Edge SB, Byrd DR, Carducci MA, et al. (eds.). American Joint Committee on Cancer (AJCC) cancer staging manual, 7th ed. New York: Springer; 2009.
25. Yuan J1, Chow SK, Yeung DK, et al., Quantitative evaluation of dual-flip-angle T1 mapping on DCE-MRI kinetic parameter estimation in head and neck. Quant Imaging Med Surg 2012; 2: 245-253.
26. Tofts PS, Brix G, Buckley DL, et al., Estimating kinetic parameters from dynamic contrast-enhanced T (1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging 1999; 10: 223-232.
27. Sobin LH, Gospodarowicz MK, Wittekind Ch, (eds.). International Union Against Cancer (UICC) TNM classification of malignant tumors, 7th ed. Oxford, UK: Wiley-Blackwell; 2009.
28. Cooper RA, Carrington BM, Loncaster JA, et al., Tumour oxygenation levels correlate with dynamic contrast-enhanced magnetic resonance imaging parameters in carcinoma of the cervix. Radiother Oncol 2000; 57: 53-59.
29. Wheeler JM, Warren BF, Jones AC, et al., Preoperative radiotherapy for rectal cancer: implications for surgeons, pathologists and radiologists. Br J Surg 1999; 86: 1108-1120.
30. de Lussanet QG1, Backes WH, Griffioen AW, et al., Dynamic contrast-enhanced magnetic resonance imaging of radiation therapy-induced microcirculation changes in rectal cancer. Int J Radiat Oncol Biol Phys 2005; 63: 1309-1315.
31. Intven M1, Reerink O, Philippens ME,. Dynamic contrast enhanced MR imaging for rectal cancer response assessment after neo-adjuvant chemoradiation. J Magn Reson Imaging 2014 [Epub ahead of print].
32. Yeo DM, Oh SN, Jung CK, et al., Correlation of dynamic contrast-enhanced MRI perfusion parameters with angiogenesis and biologic aggressiveness of rectal cancer: Preliminary results. J Magn Reson Imaging 2013 [Epub ahead of print].
33. Lambrecht M1, Deroose C, Roels S, et al., The use of FDG-PET/CT and diffusion-weighted magnetic resonance imaging for response prediction before, during and after preoperative chemoradiotherapy for rectal cancer. Acta Oncol 2010; 49: 956-963.
34. Davenport MS, Heye T, Dale BM, et al., Inter- and intra-rater reproducibility of quantitative dynamic contrast enhanced MRI using TWIST perfusion data in a uterine fibroid model. J Magn Reson Imaging 2013; 38: 329-335.